Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,953 | 304 | 96.1% |
| Education | $241.99 | 3 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $555.80 | 29 | $0 (2023) |
| Seagen Inc. | $538.13 | 26 | $0 (2023) |
| Amgen Inc. | $441.42 | 21 | $0 (2023) |
| Astellas Pharma US Inc | $323.28 | 13 | $0 (2023) |
| Janssen Biotech, Inc. | $289.46 | 11 | $0 (2023) |
| GENZYME CORPORATION | $276.63 | 13 | $0 (2024) |
| Genentech USA, Inc. | $256.70 | 15 | $0 (2023) |
| Incyte Corporation | $252.93 | 13 | $0 (2023) |
| Merck Sharp & Dohme LLC | $219.36 | 12 | $0 (2024) |
| ABBVIE INC. | $213.87 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $168.39 | 8 | Daiichi Sankyo Inc. ($51.83) |
| 2023 | $2,121 | 106 | Janssen Biotech, Inc. ($235.90) |
| 2022 | $2,224 | 112 | Seagen Inc. ($259.57) |
| 2021 | $1,681 | 81 | AstraZeneca Pharmaceuticals LP ($230.74) |
All Payment Transactions
307 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.47 | General |
| 10/17/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: Oncology | ||||||
| 07/11/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: ONCOLOGY | ||||||
| 07/05/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Oncology | ||||||
| 05/09/2024 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: Oncology | ||||||
| 04/12/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: ONCOLOGY | ||||||
| 04/12/2024 | ABBVIE INC. | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: ONCOLOGY | ||||||
| 02/28/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: ONCOLOGY | ||||||
| 12/08/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: ONCOLOGY | ||||||
| 11/30/2023 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: ONCOLOGY | ||||||
| 11/29/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug), EPKINLY | Food and Beverage | In-kind items and services | $23.09 | General |
| Category: ONCOLOGY | ||||||
| 11/27/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $18.12 | General |
| 10/23/2023 | Novartis Pharmaceuticals Corporation | PROMACTA (Drug) | Food and Beverage | In-kind items and services | $25.64 | General |
| Category: Oncology | ||||||
| 10/19/2023 | Janssen Biotech, Inc. | TECVAYLI (Biological) | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Oncology | ||||||
| 10/18/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $18.17 | General |
| 10/13/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: ONCOLOGY | ||||||
| 10/11/2023 | MorphoSys, US Inc. | MONJUVI (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Oncology | ||||||
| 10/03/2023 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: ONCOLOGY | ||||||
| 10/02/2023 | Genentech USA, Inc. | Tecentriq (Biological) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: BioOncology | ||||||
| 09/28/2023 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Oncology | ||||||
| 09/26/2023 | Seagen Inc. | PADCEV (Biological) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Oncology | ||||||
| 09/25/2023 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Oncology | ||||||
| 09/21/2023 | Janssen Biotech, Inc. | IMBRUVICA (Drug), DARZALEX | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Oncology | ||||||
| 09/21/2023 | Amgen Inc. | Blincyto (Biological), Kyprolis | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Oncology | ||||||
| 09/19/2023 | Amgen Inc. | Nplate (Biological), Vectibix, XGEVA | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Hematology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 77 | 77 | $13,490 | $3,867 |
| 2022 | 8 | 194 | 225 | $18,581 | $3,609 |
| 2021 | 13 | 314 | 352 | $44,752 | $9,008 |
| 2020 | 8 | 188 | 222 | $30,945 | $7,530 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 28 | $7,000 | $2,123 | 30.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 13 | $4,645 | $1,468 | 31.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 19 | 19 | $570.00 | $152.57 | 26.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 17 | 17 | $1,275 | $123.85 | 9.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 32 | $8,000 | $2,364 | 29.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 37 | 44 | $3,300 | $338.12 | 10.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 26 | 28 | $2,100 | $292.40 | 13.9% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2022 | 15 | 24 | $1,800 | $233.83 | 13.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 22 | 25 | $1,875 | $216.98 | 11.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 40 | 46 | $1,380 | $136.38 | 9.9% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2022 | 14 | 15 | $60.00 | $14.32 | 23.9% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 11 | 11 | $66.00 | $12.77 | 19.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 32 | 44 | $11,000 | $2,881 | 26.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 23 | 23 | $5,750 | $1,830 | 31.8% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 18 | 20 | $9,680 | $1,796 | 18.6% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 13 | 13 | $1,690 | $582.66 | 34.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 58 | 62 | $4,650 | $481.74 | 10.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 32 | 33 | $2,475 | $348.48 | 14.1% |
| 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | Office | 2021 | 11 | 13 | $2,285 | $257.01 | 11.2% |
| 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | Office | 2021 | 15 | 23 | $1,725 | $242.35 | 14.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 17 | 21 | $1,575 | $189.41 | 12.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 54 | 59 | $1,770 | $177.00 | 10.0% |
| 83550 | Iron binding capacity | Office | 2021 | 14 | 14 | $1,050 | $122.36 | 11.7% |
| 83540 | Iron level | Office | 2021 | 14 | 14 | $1,050 | $90.58 | 8.6% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2021 | 13 | 13 | $52.00 | $10.16 | 19.5% |
About Ashley Wood
Ashley Wood is a Gerontology healthcare provider based in Knoxville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/21/2019. The National Provider Identifier (NPI) number assigned to this provider is 1881230126.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ashley Wood has received a total of $6,195 in payments from pharmaceutical and medical device companies, with $168.39 received in 2024. These payments were reported across 307 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($5,953).
As a Medicare-enrolled provider, Wood has provided services to 773 Medicare beneficiaries, totaling 876 services with total Medicare billing of $24,015. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Gerontology
- Location Knoxville, TN
- Active Since 11/21/2019
- Last Updated 11/21/2019
- Taxonomy Code 363LG0600X
- Entity Type Individual
- NPI Number 1881230126
Products in Payments
- IMBRUVICA (Drug) $268.13
- LIBTAYO (Biological) $226.52
- MONJUVI (Drug) $213.80
- TUKYSA (Drug) $207.79
- KEYTRUDA (Biological) $199.87
- VENCLEXTA (Drug) $193.95
- CALQUENCE (Drug) $178.71
- PADCEV (Biological) $167.05
- OPDIVO (Biological) $159.04
- BLENREP (Biological) $135.21
- Enhertu (Drug) $132.05
- FOTIVDA (Drug) $128.94
- PADCEV (Drug) $124.67
- RYBREVANT (Drug) $124.64
- ADCETRIS (Biological) $122.36
- XGEVA (Biological) $120.94
- PROMACTA (Drug) $120.25
- LUMAKRAS (Drug) $117.43
- VENCLEXTA (Biological) $108.95
- Nplate (Biological) $103.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gerontology Doctors in Knoxville
Erann Bulman, Nurse Practitioner, NURSE PRACTITIONER
Gerontology — Payments: $8,474
Deanna Hopkins, Agnp-C, AGNP-C
Gerontology — Payments: $1,940
Chelsea Matheson
Gerontology — Payments: $1,019
Mr. Trea Tipton, Msn, Aprn, MSN, APRN
Gerontology — Payments: $186.50
Caitlin Lowe
Gerontology — Payments: $14.33
Harriet Starkey, Gnp, GNP
Gerontology